A micro-environment controllable temperature and humidity system evaluates heat and humidity comfort level of textiles. The system includes a bed-shaped partitioned platform having one or more non-temperature and humidity-controllable sections and one or more temperature and humidity controllable sections. One or more temperature and humidity control machine is in communication with the one or more temperature and humidity control sections for supplying air with a pre-set temperature and humidity. A central controller electrically is connected to the one or more temperature and humidity control machines. The micro-environment controllable temperature and humidity system can perform partitioned control on the temperature and humidity in a micro-environment during sleep, and is used for studying the influence of the temperature and humidity on the comfort level of different regions of a subject.

A flowmeter has a disposable flow tube and a part of the shutter which are in direct contact with exhaled air and protect the rest of the device from potential contamination with harmful viruses.

A micro-environment controllable temperature and humidity system evaluates heat and humidity comfort level of textiles. The system includes a bed-shaped partitioned platform having one or more non-temperature and humidity-controllable sections and one or more temperature and humidity controllable sections. One or more temperature and humidity control machine is in communication with the one or more temperature and humidity control sections for supplying air with a pre-set temperature and humidity. A central controller electrically is connected to the one or more temperature and humidity control machines. The micro-environment controllable temperature and humidity system can perform partitioned control on the temperature and humidity in a micro-environment during sleep, and is used for studying the influence of the temperature and humidity on the comfort level of different regions of a subject.

The invention provides anti-Tau antibodies and methods of using the same.

A method for determining neurotransmitter levels and/or neurotransmitter receptor sensitivity in an individual, comprising: determining a taste recognition profile of the individual for at least one taste modality prior and subsequent to the administration of a pharmaceutical for increasing neurotransmission; comparing the taste recognition profiles to determine a change; and comparing that change with corresponding measurements from a comparative database to determine neurotransmitter levels and/or neurotransmitter receptor sensitivity in the individual. In addition, a sample of a taste modality is provided for use in a method of diagnosis of a psychiatric, neurological, psychosomatic or physical disorder in an individual.

Cells are grown in 3D culture and topological features obtained by photomicrography are correlated to cell viability and cell interactions.

The invention relates to the liver-specific delivery and/or expression of an enzyme which has a deoxyribonuclease (DNase) activity for enhanced clearance of cell free DNA (cfDNA) accumulated in hepatic porto-sinusoidal circulation and the use of such liver-specific delivery and/or expression for treatment of various diseases and conditions, including cancer and neurodegeneration.

The present disclosure provides a method for treating an inflammatory neurological disease comprising administering a population of cells enriched for STRO-1.sup.+ cells and/or progeny thereof and/or soluble factors derived therefrom.

The disclosure relates to compositions and methods for treatment of diseases associated with aberrant lysosomal function, such as fronto-temporal dementia (FTD). The disclosure also provides expression constructs comprising a transgene encoding progranulin or a portion thereof. The disclosure provides methods of treating FTD by administering such expression constructs to a subject in need thereof.

Disclosed is an analytical device including at least one non-binding membrane; at least one liquid sample application region; and at least one capturing chamber including labelled particles; in which device the sample application region(s) are arranged upstream of the membrane while the capturing chamber(s) are arranged downstream of the membrane, and wherein the cut-off of the membrane is large enough to allow passage of labelled particles but small enough to retain clusters including analyte bound to particles. Also disclosed is a method of detecting one or more analytes such as biomarkers in a liquid sample such as blood using a device as disclosed.